-abine
Nucleoside drugs built on an arabinose sugar, used against viruses or cancer.
- Drugs ending in -abine: 4
- Approved somewhere: 2
- With a US drug page: 2
- Stem
- -abine
- Class
- Nucleoside drugs built on an arabinose sugar, used against viruses or cancer
- Sub-stem of
- -(ar)abine: Nucleosides built on an arabinose sugar
- Most common targets
- KCNQ (Kv7) potassium channel (1), SLC6A1 (1), CNR1 (1), CNR2 (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -abine, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Ezogabine | Approved | KCNQ (Kv7) potassium channel | KCNQ (Kv7) potassium channel opener |
| Tiagabine | Approved | SLC6A1 | GABA transporter 1 inhibitor |
| Pivagabine | Phase 2 | โ | โ |
| Nonabine | โ | CNR1, CNR2 | Cannabinoid CB1 receptor agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO